EntreMed Stockholders Approve Name Change To CASI Pharmaceuticals
Published: Jun 13, 2014
ROCKVILLE, Md., June 13, 2014 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage biopharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that at its annual meeting of stockholders held on June 12, 2014, stockholders voted in favor of changing the company's corporate name to CASI Pharmaceuticals, Inc. The name change will occur on June 16, 2014 with the Company's common stock trading on NASDAQ under the new symbol "CASI" and the rollout of a new website www.casipharmaceuticals.com.
Help employers find you! Check out all the jobs and post your resume.